GLG News by General Internal Medicine Physicians (US)

Ever since Hyaluronans (HA) have been around to lubricate the the knee, arthroplasties have declined significantly for OA. This implies that finding the precise material necessary to keep the knee capsule full will prevent further degeneration of the joint and eventually the ultimate answer to treat...

In spite of GSK's best efforts, I am feeling the vibes, both in myself and in those doctors around me, that damage control is not working.  I just attended a Teleconference with C. Beck the other night, and the moderator soundly trounced Avandia, even allowing for his being paid to speak for Takeda's...

Galvus is now approved for use in all 27 countries of the European Union, plus Norway, Iceland, Brazil, and Mexico.  It is the first in it's class to be approved for combination therapy with all three of the most commonly prescribed oral diabetic agents--metformin, sulfonyureas,...

I tracked down the proposed law online, and seems to still be in a very rough draft state;  I find it hard to believe that a doctor will be paid $1.00 per electronic prescription.  That can actually add up to a lot of money per month, and actually make me NOT groan when, at the end of a visit,...

Health insurance margins are declining.  The old model of increasing premiums or lowering health care costs is not enough to sustain profitability.  As a physician I see both sides of the 3rd party payor equation and a new model must be created to maintain profits.  There is increasing...

This seems to me, as a board certified practicing Internist, as yet another intrusion into the successful continuing concept of private practice.  As Internists, we don't just treat Lupus, heart failure, renal failure, strokes, etc.  Those conditions do require our skill and training levels,...

Something actually indicated for this disease.

Alternative drug to use.  Lower abuse potential  Lower stigma

Compliance issues  ? side effects

An oral anticoagulant that does not require monitoring.